ALLMedicine™ Rhinitis Center

May 15th, 2022 - Different treatments exist for allergic rhinitis (AR), including pharmacotherapy and allergen immunotherapy (AIT), but they have not been compared using direct patient data (i.e., "real-world data"). To compare AR pharmacological treatments on (i)...

May 14th, 2022 - To critically review the literature on nasal nitric oxide (nNO) and its current clinical and research applicability in the diagnosis and treatment of different sinonasal inflammatory diseases, including acute bacterial rhinosinusitis (ABRS), aller...

May 14th, 2022 - Asthma and allergic rhinitis (AR) are widely considered to be the most common chronic inflammatory disorders. This study was performed to investigate the clinical features, disease severity, and upper airway inflammation among patients with asthma...

May 12th, 2022 - Local nasal immunotherapy (LNIT), an alternative non-injection immunotherapy method, is theoretically an efficient method of inducing immunotolerance directly in the affected organ. LNIT is more convenient and less invasive than injection immunoth...

May 11th, 2022 - Air pollution is a serious health concern and affects inflammatory sinonasal diseases such as allergic rhinitis (AR) and chronic rhinosinusitis (CRS). Clarifying the relationship between air pollutants and upper respiratory diseases could help the...

Jul 7th, 2021 - S.J., a 68-year-old Black man, comes to your office to establish care after recently moving to the area. S.J. has a history of allergic rhinitis, osteoarthritis, and gastroesophageal reflux disease. Additionally, he has a 39-pack-year history of s...

Feb 23rd, 2020 - The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and cle...

May 12th, 2019 - To provide an evidence-based recommendation for the management of olfactory dysfunction in accordance with the consensus reached by the Subcommittee of the Japanese Clinical Practice Guideline for olfactory dysfunction in the Japanese Rhinologic S...

Nov 29th, 2017 - The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidenc...

Jun 13th, 2017 - Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lo...

Apr 27th, 2022 - Background: Shiners results from the accumulation of body fluid in the infraorbital groove. The physiology and pathology in children include nasal congestion, inflammation of nose and eyes, trauma to the nose or the forehead, facial surgery, or fac...

Apr 27th, 2022 - Background/Significance The prevalence of AR is increasing worldwide. A large number of studies have shown that AR has a significant adverse impact on the quality of life especially in the moderate-to-severe AR population. However, as AR is not a ...

Apr 25th, 2022 - Adult subjects (18-60) with documented allergic rhinitis will be assigned to placebo or probiotic groups and take either placebo or probiotic dietary intervention for 8 weeks. Total nasal symptom score (TNSS), Rhinitis Control Assessment Test (RCA...

Apr 22nd, 2022 - This is a mechanistic, controlled, open-label, single-site study to evaluate the effects of RG-RV16 inoculation on airway mucosal gene expression and airway remodeling in 25 healthy controls (HC), in 25 allergic rhinitis subjects (AR) with cat dan...

Apr 20th, 2022 - The CLARITY Study is a prospective, single-arm, multicenter safety and efficacy study of the Neurent Medical NEUROMARK System in subjects with chronic rhinitis.

May 2nd, 2022 - Mr. J, age 73, has a 25-year history of generalized anxiety disorder and major depressive disorder.

Apr 18th, 2022 - Giving the probiotic supplement Lactobacillus rhamnosus GG (LGG) to high-risk infants in the first 6 months of life is not effective in lessening incidence of eczema, asthma, or rhinitis in later childhood, researchers have found. The researchers,...

Apr 15th, 2022 - Note that some links may require registration or subscription. The U.S. test-to-treat program that launched last month has been bogged down by a lack of participating pharmacies and health centers as well as technical issues with the national webs...

Feb 25th, 2022 - Among infants and very young children, symptomatic respiratory syncytial virus (RSV) infections required greater hospital resource utilization than SARS-CoV-2 infections, a retrospective study in Germany found. Among nearly 200 symptomatic childre...

Jan 31st, 2022 - While it's well established that atopic dermatitis (AD) in adults is associated with asthma, allergic rhinitis, and other atopic conditions, the links between AD and other comorbidities are coming into clearer focus. According to new guidelines on...